全文获取类型
收费全文 | 1027篇 |
免费 | 53篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 99篇 |
妇产科学 | 9篇 |
基础医学 | 95篇 |
口腔科学 | 19篇 |
临床医学 | 117篇 |
内科学 | 212篇 |
皮肤病学 | 32篇 |
神经病学 | 33篇 |
特种医学 | 128篇 |
外科学 | 121篇 |
综合类 | 39篇 |
预防医学 | 89篇 |
眼科学 | 30篇 |
药学 | 29篇 |
1篇 | |
肿瘤学 | 29篇 |
出版年
2023年 | 6篇 |
2022年 | 6篇 |
2021年 | 18篇 |
2020年 | 11篇 |
2019年 | 13篇 |
2018年 | 15篇 |
2017年 | 8篇 |
2016年 | 14篇 |
2015年 | 20篇 |
2014年 | 24篇 |
2013年 | 28篇 |
2012年 | 18篇 |
2011年 | 24篇 |
2010年 | 45篇 |
2009年 | 36篇 |
2008年 | 34篇 |
2007年 | 55篇 |
2006年 | 46篇 |
2005年 | 41篇 |
2004年 | 46篇 |
2003年 | 37篇 |
2002年 | 33篇 |
2001年 | 27篇 |
2000年 | 25篇 |
1999年 | 27篇 |
1998年 | 44篇 |
1997年 | 53篇 |
1996年 | 41篇 |
1995年 | 22篇 |
1994年 | 35篇 |
1993年 | 24篇 |
1992年 | 17篇 |
1991年 | 16篇 |
1990年 | 15篇 |
1989年 | 30篇 |
1988年 | 21篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1984年 | 16篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1969年 | 2篇 |
1946年 | 2篇 |
1921年 | 1篇 |
排序方式: 共有1085条查询结果,搜索用时 0 毫秒
131.
Prader–Willi syndrome 总被引:1,自引:0,他引:1
RTL Couper 《Journal of paediatrics and child health》1999,35(4):331-334
Prader-Willi syndrome is a multi system disorder characterized by neonatal hypotonia, later obesity, hyperphagia and mental retardation. It occurs sporadically, either as a result of microdeletion of chromosome 15p (70%) or as a result of maternal disomy of chromosome 15 (30%). The major problems encountered by parents are those of hyperphagia, food-seeking and obesity, and conduct disorder, particularly tantrums or oppositional behaviour. 相似文献
132.
133.
M.?G.?SawyerEmail author K.?E.?Reynolds J.?J.?Couper D.?J.?French D.?Kennedy J.?Martin R.?Staugas P.?A.?Baghurst 《Quality of life research》2005,14(2):395-405
The aim of this study was to assess prospectively changes in the health-related quality of life (HRQL) of children and adolescents with diabetes, asthma or cystic fibrosis (CF). One hundred and twenty-two parents of children aged 10–16 years with asthma, diabetes, or CF were recruited from specialist paediatric clinics. Parents described their childrens HRQL using the Child Health Questionnaire (PF98) at baseline, 6, 12, 18 and 24 months post-baseline. They reported that the general health of children with CF was significantly worse than that of children with asthma and diabetes at baseline. In other domains there were few differences between the HRQL of children in the three groups. In several domains, the HRQL of children with asthma or diabetes improved over the 2years of the study. This improvement was less evident for children with CF. 相似文献
134.
135.
Waldmann TA; Goldman CK; Bongiovanni KF; Sharrow SO; Davey MP; Cease KB; Greenberg SJ; Longo DL 《Blood》1988,72(5):1805-1816
Human T-cell lymphotropic virus I (HTLV-I)-induced adult T-cell leukemia (ATL) cells constitutively express interleukin-2 (IL-2) receptors identified by the anti-Tac monoclonal antibody (MoAb), whereas normal resting cells do not. This observation provided the scientific basis for a trial of intravenous anti-Tac in the treatment of nine patients with ATL. The patients did not suffer untoward reactions and did not have a reduction in the normal formed elements of the blood, and only one of the nine produced antibodies to the anti-Tac MoAb. Three patients had transient mixed, partial, or complete remissions lasting from 1 to more than 8 months after anti-Tac therapy, as assessed by routine hematologic tests, immunofluorescence analysis of circulating cells, and molecular genetic analysis of HTLV-I provirus integration and of the T-cell receptor gene rearrangement. The precise mechanism of the antitumor effects is unclear; however, the use of a MoAb that prevents the interaction of IL-2 with its receptor on ATL cells provides a rational approach for the treatment of this malignancy. 相似文献
136.
To determine the incidence of transfusion-associated human immunodeficiency virus (HIV) infection after routine screening of donated blood, a pilot study estimated the pretransfusion prevalence of HIV infection among blood product recipients in San Francisco. Among the 911 nonduplicate pretransfusion specimens from recipients without a clinical history of acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC), the overall prevalence of antibody to HIV was 2.9 percent (5.2% among males and 0.6% among females; p = 0.00002). If recipients in specifically defined or possible high-risk groups (n = 348) were excluded, a seropositivity rate of 1.8 percent (10/563) was detected, with all the positives occurring in men (10/242, 4.1%) and none in women (0/321, 0%). This demonstrated prevalence of HIV infection among blood product recipients in San Francisco before transfusion was substantially higher than the known 0.02 to 0.04 percent prevalence in the donor population. Therefore, the population of women without known risk for AIDS is the best in which to assess the risk of HIV infection in patients who are currently receiving seronegative blood transfusions. 相似文献
137.
138.
139.
Murakami T; Baron RL; Peterson MS; Oliver JH rd; Davis PL; Confer SR; Federle MP 《Radiology》1996,200(1):69
140.
J-B Liu† M Li‡§ H Chen† S-Q Zhong† S Yang¶ W-D Du¶ J-H Hao†† T-S Zhang‡‡ X-J Zhang¶ MP Zeegers§§¶¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(2):205-213
BACKGROUND: Linkage and association studies suggest that the human leucocyte antigen (HLA) region may be involved in the genetic susceptibility of vitiligo. HLA-A2 has been reported to be associated with vitiligo in some, but not all, studies. OBJECTIVE: To identify sources of the heterogeneity among studies and to quantify effect estimates, we examined the association of HLA-A2 with vitiligo in a meta-analysis of all observational studies comparing the frequencies of HLA-A2 between vitiligo individuals and controls during 1966-2005. METHODS: The summary odds ratio (OR) was calculated by using a fixed- or a random-effects model. Meta-regression analysis was undertaken to investigate the effects of study characteristics on the pooled OR. RESULTS: Eleven case-controlled studies fulfilled our inclusion criteria. The studies identified a total of 777 patients and 4820 controls. Meta-analysis showed a significantly increased frequency of HLA-A2 in vitiligo among cases [OR = 2.07, 95% confidence interval (CI) 1.67-2.58]. Heterogeneity was explained by the quality of the study and the ethnic background of the participants. Meta-regression analysis further showed that the percentage of familial vitiligo among the subjects had a significant effect on the pooled OR (P = 0.008). No study had a significant effect on the pooled OR and no publication bias presented in the studies analysed (P = 0.688). CONCLUSION: These findings strongly suggest an association between HLA-A2 and vitiligo. 相似文献